Abstracts

934 – Evidence of B-Cell Dysfunction in Individuals With Long COVID-Associated Dysautonomia

Background Long COVID (LC) can trigger dysautonomia or dysfunction of the autonomic nervous system (ANS) similar to some autoimmune diseases. Dysautonomia has been related with autoantibodies produced by activated non-specific B-cell clones that may interfere with the ANS normal function. Our objective was to analyze alterations in the humoral immunity with a specific focus on…

838 – Risk of Obesity, Cardiometabolic Disease, and MACE After Switch to Integrase Inhibitor in REPRIEVE

Background Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) has been associated with disproportionate weight gain among people with HIV (PWH), primarily in treatment-naïve populations. Few studies have explored weight and cardiometabolic outcomes beyond two years and even fewer have examined effects on major adverse cardiovascular events (MACE). Methods Using target trial emulation, we estimated…

1046 – Safety and Pharmacokinetics of Long-Acting Cabotegravir and Rilpivirine in Children 20 to 40 kg

Background Long-acting cabotegravir (CAB-LA) plus long-acting rilpivirine (RPV-LA) are approved for maintenance of viral suppression in adults and adolescents >35kg with HIV-1 infection. IMPAACT 2036 (CRAYON) is a Phase I/II, multi-center, open-label, non-comparative study to evaluate safety, tolerability, acceptability and pharmacokinetics (PK) of oral (PO) and intramuscular (IM) CAB-LA+RPV-LA in children 2-<12 years, living with HIV-1.…

975 – Trends in Cryptococcal Meningitis Mortality Using Routine Longitudinal National Data From Botswana

Background Cryptococcal meningitis (CM) remains a frequent opportunistic infection among individuals with advanced HIV disease, causing significant morbidity and mortality. CM incidence has fallen in high HIV-prevalence settings with expansion of ART. Few countries other than South Africa collect reliable data on CM; robust longitudinal data describing the impact of HIV programme interventions and changes…